Procter & Gamble Health Limited (BOM:500126)
5,651.65
-69.75 (-1.22%)
At close: May 26, 2026
Procter & Gamble Health Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 1,853 | 1,821 | 2,385 | 4,351 | 3,194 |
Cash & Short-Term Investments | 1,853 | 1,821 | 2,385 | 4,351 | 3,194 |
Cash Growth | 1.76% | -23.66% | -45.18% | 36.21% | -31.17% |
Accounts Receivable | 1,643 | 1,454 | 853.3 | 1,157 | 834.4 |
Other Receivables | - | 175.1 | 133.7 | 125.6 | 74.6 |
Receivables | 1,664 | 1,645 | 1,004 | 1,298 | 924.7 |
Inventory | 1,367 | 1,094 | 1,091 | 1,349 | 1,152 |
Prepaid Expenses | - | 45.1 | 18 | 11.7 | 4.9 |
Other Current Assets | 679.7 | 659.3 | 743.9 | 951.4 | 804.7 |
Total Current Assets | 5,563 | 5,264 | 5,242 | 7,961 | 6,080 |
Property, Plant & Equipment | 1,128 | 1,220 | 1,315 | 1,733 | 1,496 |
Other Intangible Assets | 4.7 | 7.1 | 9.6 | 9.4 | 0.4 |
Long-Term Deferred Tax Assets | 307 | 350.6 | 336.9 | 253.2 | 196.5 |
Other Long-Term Assets | 1,289 | 998.8 | 942.2 | 992.6 | 1,048 |
Total Assets | 8,414 | 7,942 | 7,944 | 11,012 | 8,881 |
Accounts Payable | 1,922 | 1,716 | 1,670 | 2,370 | 1,721 |
Accrued Expenses | - | 207.9 | 241.2 | 254.4 | 356.1 |
Current Portion of Leases | 35.7 | 28.1 | 26.8 | 31.2 | 28.3 |
Current Income Taxes Payable | 87.7 | 34.5 | 34.5 | 61.3 | 72.4 |
Current Unearned Revenue | - | - | 0.8 | 1.2 | 1.6 |
Other Current Liabilities | 504.2 | 166.6 | 215.8 | 320.5 | 139.8 |
Total Current Liabilities | 2,549 | 2,153 | 2,189 | 3,039 | 2,319 |
Long-Term Leases | 57.2 | 48.1 | 68.8 | 88.8 | - |
Other Long-Term Liabilities | 561.5 | 371.2 | 303.3 | 375.2 | 397.3 |
Total Liabilities | 3,168 | 2,572 | 2,561 | 3,503 | 2,716 |
Common Stock | 166 | 166 | 166 | 166 | 166 |
Additional Paid-In Capital | - | 111.3 | 111.3 | 111.3 | 111.3 |
Retained Earnings | - | 5,038 | 5,015 | 7,148 | 5,810 |
Comprehensive Income & Other | 5,080 | 54.1 | 90.5 | 83.6 | 78 |
Shareholders' Equity | 5,246 | 5,370 | 5,382 | 7,509 | 6,165 |
Total Liabilities & Equity | 8,414 | 7,942 | 7,944 | 11,012 | 8,881 |
Total Debt | 92.9 | 76.2 | 95.6 | 120 | 28.3 |
Net Cash (Debt) | 1,760 | 1,745 | 2,289 | 4,231 | 3,166 |
Net Cash Growth | 0.88% | -23.80% | -45.88% | 33.64% | -30.64% |
Net Cash Per Share | 106.03 | 105.10 | 137.92 | 254.86 | 190.71 |
Filing Date Shares Outstanding | 16.6 | 16.6 | 16.6 | 16.6 | 16.6 |
Total Common Shares Outstanding | 16.6 | 16.6 | 16.6 | 16.6 | 16.6 |
Working Capital | 3,013 | 3,111 | 3,053 | 4,922 | 3,761 |
Book Value Per Share | 316.01 | 323.48 | 324.25 | 452.36 | 371.39 |
Tangible Book Value | 5,241 | 5,363 | 5,373 | 7,500 | 6,165 |
Tangible Book Value Per Share | 315.72 | 323.05 | 323.67 | 451.79 | 371.37 |
Land | - | 4.5 | 5 | 5 | 5 |
Buildings | - | 513.4 | 561.2 | 538.9 | 542.9 |
Machinery | - | 1,472 | 1,438 | 1,855 | 1,710 |
Construction In Progress | - | 109.6 | 58.9 | 324.9 | 406 |
Leasehold Improvements | - | 79.1 | 79 | 78.6 | 6.8 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.